首页> 外国专利> Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells

Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells

机译:用培养的细胞生产日本血凝病毒和腺病毒的方法

摘要

A novel cell suited for mass production of Hemagglutinating Virus of Japan (HVJ), a method for obtaining the cell and use of the cell are disclosed. The human cell is originated from a transformed human kidney cell line, the doubling time thereof in logarithmic growth phase in suspension culture in a serum-free medium is not more than 40 hours, the cell has a freeze-recovery property, the maximum density of viable cells in suspension culture is not less than 106 cells/mL, and HVJ can grow in the cell. The method for obtaining the human cell comprises the steps of suspension-culturing a human transformed kidney cell line in a serum-free medium, and cloning the grown cells; and selecting, from the cloned cells, a cell whose doubling time in logarithmic growth phase in suspension culture in a serum-free medium is not more than 40 hours, which has a freeze-recovery property, whose maximum density of viable cells in suspension culture is not less than 106 cells/mL, in which HVJ can grow.
机译:公开了适用于大规模生产日本血凝病毒(HVJ)的新型细胞,获得该细胞的方法和该细胞的用途。人细胞起源于转化的人肾细胞系,在无血清培养基中悬浮培养的对数生长期的倍增时间不超过40小时,具有冷冻恢复特性,最大密度悬浮培养的活细胞不少于10 6 细胞/ mL,HVJ可以在细胞中生长。获得人细胞的方法包括以下步骤:将人转化的肾细胞系在无血清培养基中悬浮培养,然后克隆生长的细胞。从克隆的细胞中选择在无血清培养基中悬浮培养对数生长期的倍增时间不超过40小时的细胞,该细胞具有冷冻恢复特性,其悬浮培养中活细胞的最大密度不低于10 6 细胞/ mL,其中HVJ可以生长。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号